Servier
BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design
July 11, 2025Research and Development BioLabs, BioMed X, Cancer, Oncology, Servier, XSeed Labs, antibody therapy, oncology
BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, located at the Spartners incubator …
Servier and Aitia enter into R&D collaboration for pancreatic cancer using Digital Twins
May 18, 2023Research and Development Aitia, Digital Twins, Oncology, Pancreatic cancer, Servier
French pharmaceutical company Servier and US-based Causal AI and Digital Twins company Aitia have announced a collaboration to create Digital …
Servier and MiNA partner to develop neurological disorder treatments
January 22, 2021Medical Communications MiNA, Servier
Independent pharmaceutical group Servier and RNA activation-focused MiNA Therapeutics have entered a research partnership to identify and develop small activating …
Shire hands over its oncology franchise to Servier for $2.4bn
August 31, 2018Medical Communications, Sales and Marketing Cancer, Servier, Shire, oncology, pharma, sale
Shire has completed the sale of its oncology franchise to French firm Servier for $2.4 billion, handing over the global …
Shire jettisons oncology unit for $2.4bn, unbalancing Takeda deal
April 16, 2018Sales and Marketing Servier, Shire, Takeda, biotech, drugs, oncology, pharma, pharmaceutical
Shire has announced that it has entered a definitive agreement for French drugmaker Servier to take on its oncology business. …
Servier fights fine over antitrust breaches
June 7, 2017Manufacturing and Production, Research and Development, Sales and Marketing European Commission, Servier, generic
Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust …
Servier UK appoints new chief executive
December 18, 2015Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier
Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …
France Focus: Power without responsibility?
October 27, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report
Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …
Servier slammed over UK trial transparency failure
September 8, 2014Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials
Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …
Servier fined €331m by European Commission
July 10, 2014Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva
The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …
Servier signs leukaemia deal
February 19, 2014Research and Development, Sales and Marketing Servier, UCART19, car, cellectis, leaukaemia
French firms Servier and small biopharma cancer specialist Cellectis have signed a deal to develop and commercialise one drug targeting …
Servier signs cancer partnership
January 29, 2014Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie
Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …
Amgen signs Servier deal
July 11, 2013Sales and Marketing Amgen, Servier, heart, procoloran
Amgen has gained rights in the US to two of Servier’s heart drugs: the novel, oral Procoralan and investigational Phase …
Boehringer wins contract to make Servier’s gevokizumab
August 7, 2012Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody
Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …
Misinformation charges against Servier dropped
January 30, 2012Sales and Marketing European Commission, Servier, anti-competitive behaviour
The European Commission has dropped a case against Servier in which the French manufacturer was accused of providing misleading information.The …
